Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients

Major depression disorder (MDD) is the most widespread mental disorder. Selective serotonin reuptake inhibitors (SSRIs) are used as first-line MDD treatment but are effective in <70% of patients. Thus, biomarkers for the early identification of treatment-resistant (TR) MDD patients are needed for...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Psychiatry
Glavni autori: Rzezniczek, S, Obuchowicz, M, Datka, W, Siwek, M, Dudek, D, Kmiotek, K, Oved, K, Shomron, N, Gurwitz, D, Pilc, A
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5545648/
https://ncbi.nlm.nih.gov/pubmed/27244236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tp.2016.90
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items